Evidence map›Paper›PMID 40993125›Full record

ArticleNature communications2025

A foundation model for human-AI collaboration in medical literature mining.

Zifeng Wang, Lang Cao, Qiao Jin, Joey Chan, Nicholas Wan, Behdad Afzali, Hyun-Jin Cho, Chang-In Choi, Mehdi Emamverdi, Manjot K Gill and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Medea: An omics AI agent for therapeutic discovery.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Zifeng WangKeiji AI, Seattle, WA, USA. zifeng@keiji.ai.
Lang CaoSchool of Computing and Data Science, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Qiao JinDivision of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-1268-7239
Joey ChanDivision of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Nicholas WanDivision of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Behdad AfzaliKidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-2968-1156
Hyun-Jin ChoCenter for Advanced Medical Computing and Analysis, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Chang-In ChoiCenter for Advanced Medical Computing and Analysis, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1920-1879
Mehdi EmamverdiNational Eye Institute, National Institutes of Health, Bethesda, MD, USA.
Manjot K GillDepartment of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-6933-9331
Sun-Hyung KimCenter for Advanced Medical Computing and Analysis, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Yijia LiDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-5300-0571
Yi LiuDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA.
Yiming LuoDivision of Rheumatology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Hanley OngDepartment of Radiology, Weill Cornell Medicine, New York, NY, USA.
Justin F RousseauDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-2817-9124
Irfan SheikhDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Jenny J WeiDepartment of Dermatology, University of Washington, Seattle, WA, USA.
Ziyang XuDepartment of Dermatology, NYU Langone Health, New York, NY, USA.
Christopher M ZallekOSF HealthCare Illinois Neurological Institute, Peoria, IL, USA.
Kyungsang KimCenter for Advanced Medical Computing and Analysis, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Yifan PengDepartment of Radiology, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-9309-8331
Zhiyong LuDivision of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Jimeng SunKeiji AI, Seattle, WA, USA. jimeng@illinois.edu.ORCID http://orcid.org/0000-0003-1512-6426

Funding

Unravelling immunoregulatory circuits of tissue inflammationZIADK075149 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI AFZALI, BEHDAD · 2019 to 2025
$19.3M
ClinEX - Clinical Evidence Extraction, Representation, and AppraisalR01LM014344 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yong Chen, Yifan Peng · 2023 to 2026
$2.7M
Closing the loop with an automatic referral population and summarization systemR01LM014306 · NLM · WEILL MEDICAL COLL OF CORNELL UNIV · PI Yifan Peng, Justin Frederick Rousseau · 2023 to 2026
$2.7M
A New Therapy for Bowel Ischemia-Reperfusion InjuryR44DK075149 · NIDDK · THERASOURCE, LLC · PI JACOB, ASHA · 2010 to 2012
$1.2M
Extraction and summarization of evidence-based medicineR01LM014573 · NLM · WEILL MEDICAL COLL OF CORNELL UNIV · PI Yifan Peng, CHUNHUA WENG · 2024 to 2026
$1.1M
New Therapy for Bowel Ischemia-Reperfusion InjuryR43DK075149 · NIDDK · THERASOURCE, LLC · PI WU, RONGQIAN · 2006 to 2007
$288k
Intramural NIH HHS ZIA DK075149NIDDK NIH HHS R43 DK075149NIDDK NIH HHS R44 DK075149NLM NIH HHS R01 LM014306NLM NIH HHS R01 LM014344NLM NIH HHS R01 LM014573
6 · The paper itself

Abstract

Applying artificial intelligence (AI) for systematic literature review holds great potential for enhancing evidence-based medicine, yet has been limited by insufficient training and evaluation. Here, we present LEADS, an AI foundation model trained on 633,759 samples curated from 21,335 systematic reviews, 453,625 clinical trial publications, and 27,015 clinical trial registries. In experiments, LEADS demonstrates consistent improvements over four cutting-edge large language models (LLMs) on six literature mining tasks, e.g., study search, screening, and data extraction. We conduct a user study with 16 clinicians and researchers from 14 institutions to assess the utility of LEADS integrated into the expert workflow. In study selection, experts using LEADS achieve 0.81 recall vs. 0.78 without, saving 20.8% time. For data extraction, accuracy reached 0.85 vs. 0.80, with 26.9% time savings. These findings encourage future work on leveraging high-quality domain data to build specialized LLMs that outperform generic models and enhance expert productivity in literature mining.

Indexed as

Artificial IntelligenceData MiningEvidence-Based MedicineHumans

Identifiers

PMID40993125
PMCPMC12460617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.